Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-85.66%
↑ 99% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-11643.78%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -85.66% | +85.6% |
| 2024 | -592.93% | +95.8% |
| 2023 | -14099.34% | +80.4% |
| 2022 | -71966.19% | -147.1% |
| 2021 | -29126.85% | -16906.5% |
| 2020 | -171.27% | -471.6% |
| 2019 | 46.09% | +130.3% |
| 2018 | -152.02% | -9.6% |
| 2017 | -138.67% | +8.1% |
| 2016 | -150.97% | - |